SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,225,149 | -37.5% | 84,352 | -41.0% | 0.00% | -50.0% |
| Q2 2023 | $16,362,962 | -15.5% | 142,883 | +1.7% | 0.01% | -25.0% |
| Q1 2023 | $19,363,737 | -14.2% | 140,490 | -19.3% | 0.01% | -20.0% |
| Q4 2022 | $22,568,171 | +129.8% | 174,164 | +96.0% | 0.01% | +150.0% |
| Q3 2022 | $9,820,000 | +62.0% | 88,837 | +9.8% | 0.00% | +33.3% |
| Q2 2022 | $6,062,000 | -61.3% | 80,874 | -59.7% | 0.00% | -40.0% |
| Q1 2022 | $15,662,000 | -55.7% | 200,492 | -48.9% | 0.01% | -54.5% |
| Q4 2021 | $35,347,000 | +50.5% | 392,524 | +54.6% | 0.01% | +37.5% |
| Q3 2021 | $23,484,000 | +47.6% | 253,926 | +24.1% | 0.01% | +33.3% |
| Q2 2021 | $15,907,000 | -61.3% | 204,625 | -62.9% | 0.01% | -70.0% |
| Q1 2021 | $41,136,000 | -55.1% | 551,946 | +2.7% | 0.02% | -56.5% |
| Q4 2020 | $91,596,000 | +33.9% | 537,248 | +10.3% | 0.05% | +9.5% |
| Q3 2020 | $68,404,000 | +44.5% | 487,097 | +65.0% | 0.04% | +20.0% |
| Q2 2020 | $47,348,000 | +932.0% | 295,298 | +529.6% | 0.04% | +600.0% |
| Q1 2020 | $4,588,000 | -82.0% | 46,904 | -76.2% | 0.01% | -85.7% |
| Q4 2019 | $25,425,000 | +233.9% | 197,035 | +94.9% | 0.04% | +169.2% |
| Q3 2019 | $7,615,000 | -77.0% | 101,104 | -53.7% | 0.01% | -78.0% |
| Q2 2019 | $33,154,000 | +74.1% | 218,194 | +36.5% | 0.06% | +90.3% |
| Q1 2019 | $19,047,000 | +345.1% | 159,802 | +307.6% | 0.03% | +210.0% |
| Q4 2018 | $4,279,000 | +62.9% | 39,207 | +141.1% | 0.01% | +100.0% |
| Q3 2018 | $2,626,000 | -92.3% | 16,259 | -93.7% | 0.01% | -93.8% |
| Q2 2018 | $33,885,000 | +903.1% | 256,362 | +462.4% | 0.08% | +788.9% |
| Q1 2018 | $3,378,000 | -36.5% | 45,587 | -52.3% | 0.01% | -40.0% |
| Q4 2017 | $5,319,000 | -16.8% | 95,607 | -32.1% | 0.02% | -25.0% |
| Q3 2017 | $6,392,000 | +481.1% | 140,894 | +331.5% | 0.02% | +400.0% |
| Q2 2017 | $1,100,000 | +21.8% | 32,651 | +7.1% | 0.00% | 0.0% |
| Q1 2017 | $903,000 | -78.1% | 30,500 | -79.8% | 0.00% | -78.9% |
| Q4 2016 | $4,132,000 | -81.5% | 150,620 | -58.5% | 0.02% | -82.2% |
| Q3 2016 | $22,294,000 | +182.9% | 363,047 | -12.1% | 0.11% | +167.5% |
| Q2 2016 | $7,881,000 | +83.7% | 413,247 | +88.0% | 0.04% | +66.7% |
| Q1 2016 | $4,291,000 | +46.8% | 219,841 | +190.0% | 0.02% | +33.3% |
| Q4 2015 | $2,924,000 | +4.7% | 75,813 | -12.9% | 0.02% | 0.0% |
| Q3 2015 | $2,794,000 | +46.5% | 87,008 | +38.8% | 0.02% | +38.5% |
| Q2 2015 | $1,907,000 | +743.8% | 62,694 | +267.9% | 0.01% | +550.0% |
| Q1 2015 | $226,000 | – | 17,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |